PorA types in Neisseria meningitidis serogroup B isolated in Argentina from 2001 to 2003: implications for the design of an outer membrane protein-based vaccine
- 1 March 2008
- journal article
- Published by Microbiology Society in Journal of Medical Microbiology
- Vol. 57 (3) , 338-342
- https://doi.org/10.1099/jmm.0.47631-0
Abstract
Identification ofNeisseria meningitidisPorA types remains important, as the PorA protein is a major immunogenic component of several meningococcal vaccines under development. In this study, 191N. meningitidisserogroup B isolates collected in Argentina through active laboratory-based surveillance from 2001 to 2003 were serosubtyped. Nucleotide sequences of theporAvariable region 1 (VR1) and VR2 regions were determined in 52 non-serosubtypeable isolates. A substantial number of distinct VR types were identified, and a new VR2 variant from the P1.16 family was described. This is the first report describing PorA types inN. meningitidisserogroup B isolates in Argentina. Furthermore, the wide diversity of subtypes detected by serosubtyping and genosubtyping reveals the difficulty in designing a useful outer-membrane vaccine applicable in this country. A possible mechanism responsible for altered PorA expression was analysed in two PorA types.Keywords
This publication has 33 references indexed in Scilit:
- Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001Journal of Medical Microbiology, 2006
- Prevalence of genosubtypes (PorA types) of serogroup B invasive meningococcus in the north of Spain from 2000 to 2003Journal of Medical Microbiology, 2005
- Analysis of PorA variable region 3 in meningococci: implications for vaccine policy?Vaccine, 2003
- The meningococcus tamed?Archives of Disease in Childhood, 2002
- Serosubtypes and PorA Types of Neisseria meningitidis Serogroup B Isolated in Brazil during 1997-1998: Overview and Implications for Vaccine DevelopmentJournal of Clinical Microbiology, 2001
- Diversity and Prevalence of PorA Types inNeisseria meningitidisSerogroup B in the United States, 1992–1998The Journal of Infectious Diseases, 2000
- Phase I clinical trial with a hexavalent PorA containing meningococcal outer membrane vesicle vaccineVaccine, 1996
- Comparison of the class 1 outer membrane proteins of eight serological reference strains of Neisseria meningitidisMolecular Microbiology, 1991
- Whole-cell ELISA for typingNeisseria meningitidiswith monoclonal antibodiesFEMS Microbiology Letters, 1987
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970